[12.10 Night Review]Da Shen Lin: medicine retail leader+no pressure above+foreign capital setting up hospital access+December medical news.Broad base can give priority to GEM ETF.
China Free: Interest rate cut, import expectation+consumption tax exemption+Hainan customs clearance.Xingxin new material: semiconductor+sub-new bottom sideways shrinkage, heavy volume started today.
Da Shen Lin: medicine retail leader+no pressure above+foreign capital setting up hospital access+December medical news.Da Shen Lin: medicine retail leader+no pressure above+foreign capital setting up hospital access+December medical news.Xingxin new material: semiconductor+sub-new bottom sideways shrinkage, heavy volume started today.
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14